Pharmacology in Pregnancy and Breast feeding Flashcards
Introduction
- Majority of women take medication during pregnancy
- Many pregnancies will be unplanned
- Must consider effect of pregnancy when prescribing to any women of childbearing age
Why are medications used during pregnancies
- Hypertension
- Asthma
- Epilespy
- Mental health issue
- Migraines
- Long-term anticoagulant therapy
Why is pharmacology during pregnancy so complex
- Very little pharmacokinetic studies of medicaitons during pregnancy
- Datae is limited
Absorption changes during pregnancy
- Oral route
- Morning sickness causing nausea/ vomitting
- Decreased gastric emptying and gut motility (more likely to affect single dose medications)
- IM and SC route -> increased blood flow, increased absorption of medications
- Inhalation -> increased cardiac output and tidal volume, increased absoprtion of medications
Distribution changes during pregnancy
- Increased volume of distribution due to:
- Increased plasma volume
- Increased fat composition
- Increased fraction of unbound drugs in plasma
- Greater proportion of plasma to plasma protein
- More dilution
Metabolism changes in pregancy
- Oestrogen and progestrogen can alter P450 liver enzme
- Causes changes in metabolism
- E.g
- Phenytoin levels reduced, metabolism increases
- Theophylline levels increase, metabolism decreases
Excretory changes
- Increased GFR by 50% during pregnancy
- Increased excretion of medications
- Reduced plasma concentration of medications
- Therapeutic levels of medications require an increased dose
Pharmacokinetics vs pharmacodynamics
- Pharmacokinetics (what the body does to the drug)
- Pharmacodynamics (what the drug does to the body)
Pharmacodynamic changes in prgenancy
- Affects site of action and response of receptor to drug
- Concentration of the drug
- Presence of metabolites at site
- Changes to the receptor
- Changes in efficacy
- Less understood and can have different adverse reactions
Factors affecting drug tranfer across placenta
- Properties of the drug
- Rate of drug tranfer across placenta and amount reaching fetus
- Duration of exposure
- Distribution in fetal tissue
- Stage of placental and fetal development
- Combination effects of drugs
Factors affecting placental transfer of medications
- Molecular weight og medicaitons
- Polarity
- Lipid solubility
- Placental metabolism of medication
- Assume all medications can cross placenta**
Distribution of medications in fetus
- Different circulatory system (umbilical vein -> liver)
- Less plasma protein to adults (more free drug available)
- Little fat (less lipid distribution of medications)
- More bloodflow to brain
Metabolism of medications in fetus
- Different P450 enzyme to adults (isoenzyme)
- Reduce enzyme activity (increases with gestation)
- Excretion of medicaitons in fetus
- Fetal excretion into amniotic fluid -> swallowed then recirculated
- Drugs/ metabolites accummulate in amniotic fluid
- Non-functioning placenta during delivery (causes
Teratotoxicity vs fetotoxicity
- Teratotoxicity (fiest trimester)
- Fetotoxicity (second and third trinemester)
Principles of prescribing when planning on conceiving
- Consider effects of any medication on women of childbearing age
- Warn them of the risk
- Optimise treatment of medical condiiton prior to planning to conceive
- Discuss contraception in those taking teratogenic medications
- Do not prescribe without contraception
Principles of prescribing during pregnancy
- Try non-pharmacological treatment prior
- Medication with best safety record
- Use lowest effect dose
- Use for shortest time possible
- Avoid in first 10 weeks of pregnancy
- Consider stopping, redcuing dose before delivery
- Never undertreat disease (harmful to baby and mother)
Highest risk period of teratotoxicity
- Organogensis (weeks 3-8)
Mechanisms of teratotoxicity
- Folate antagonism
- Neural crest disruption
- Endocrine dysruption (sex hormones)
- Oxidative stress
- Vascular disruption
- Specific receptor dysruptions/ enzyme-mediated teratogenesis
Folate antagonism
- Folate function: DNA formation and cell cycle
- Antagnistic drugs
- Blocks folate -> THF conversion (methotrexate, trimethaprim)
- Blocks other enzymes in folate pathway (phenytoin, carbamazepine, sodium valoproate)
- Effects: neural tube, oro-facial, limb defects
Neural crest cell dysruption
- Drugs: retinoid drugs (isotretinoin)
- Effects
- Aortic arch defects
- Ventricular septal defect
- Craniofascial malformations
- Oesophageal atresia
- Pharyngeal gland abnormalities
*
Enzyme-mediated teratogenesis
- Any drugs inhibiting/ stimulating enzymes to cause therapeutic effect
- E.g -> NSAIDS (orofacial clefts, cardiac septal defects)
Consequences of fetotoxicity
- Growth retardation
- Structural malformations
- Fetal death
- Functional impairment
- Carcinogensis
ACEI/ARB (renal dysfunction and growth retardation)
Effect of anticonvulsants during pregnancy
- Neural tuve defects
-
Sodium valoproae, carbamazepine, phenytoin
*
Effects of anticoagulants during pregnancy
- Fetal haemorrhage
- Multiple CNS and skeletal maformations
- Warfarin, heparin, aspirin
Antihypertensive agents
- Renal damage
- Restricted growth patterns
- ACEI/ARB
Effect of NSAIDS on pregnancy
- Premature closure of ductus arteriosus
Effects of retinoids on pregnancy
- Ear, CNS, cardiovascular and skeletal disorders
Issues associated with drugs and lactation
- All drugs taken by mother present in breast milk
- Must minimise exposure of drug to neonate/ infant
- Monitor infant blood levels of drug
- Remember herbal mediations
Drugs to avoid during breastfeeding
- Cytotoxins
- Immunosupressants
- Anticonvulsants
- Drugs of absue
- Amiodarone
- Lithium
- Radio-iodine
Possible effects of medications during lactation
- Tetracycline -> permanent tooth decay
- Isoniazid -> pyroxidine deficiency
- Barbiturates -> lethargy, sedation, poor suckling
- Chloral hydrates -> drowsniness
- Diazepam -> drug accumulation and sedation
- Methadone -> withdrawal if breastfeeding stops
- Iodine -> thyroid suppression, risk of cancer
- Propylthiouracil -> thyroid function suppression
Principles of prescribing in breast feeding
- Avoid unecessary use
- Safe if licenced in paediatric use
- Choose drug with exposure reducing pharmacokinetics (highly protein bound)